JACKSON, Miss. – St. Dominic Hospital recently acquired the DigniCap Scalp Cooling System to minimize hair loss from chemo-therapy. Positive results from the multi-center FDA clinical trial, published in February 2017 by The Journal of the American Medical Association (JAMA), indicate that seven out of ten patients using the DigniCap® system kept at least 50% of their hair.
FDA-cleared since 2015, the DigniCap® Scalp Cooling System minimizes hair loss from certain chemotherapy treatments for women and men with solid tumor cancers such as those associated with breast, ovarian, uterine, prostate and other tissues.
“For many patients hair loss is a very troublesome side effect of chemotherapy,” said Christy Haygood, MD, Gynecologic Oncologist. “DigniCap provides patients with a means to reduce hair loss while maintaining their privacy and self-esteem. We believe this is a significant advantage in caring for the whole patient and are proud to make this technology available to patients at St. Dominic’s.”